Enhanced Antigen-Specific Antitumor Immunity with Altered Peptide Ligands that Stabilize the MHC-Peptide-TCR Complex

This publication has 57 references indexed in Scilit:

• A colon tumor model for anticancer agent evaluation
  Cancer, 2006
• Therapeutic Vaccination for Cancer
  Clinical Immunology, 2000
• Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120
  Journal of Molecular Biology, 1998
• LIGAND RECOGNITION BY αβ T CELL RECEPTORS
  Annual Review of Immunology, 1998
• Identification of Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes
  Methods, 1997
• Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues.
  The Journal of Experimental Medicine, 1994
• Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines
  Science, 1994
• The Bacterial and Mouse Mammary Tumor Virus Superantigens; Two Different Families of Proteins with the Same Functions
  Immunological Reviews, 1993
• Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex.
  The Journal of Experimental Medicine, 1992
• T-lymphocyte response to cytochrome c. I. Demonstration of a T-cell heteroclitic proliferative response and identification of a topographic antigenic determinant on pigeon cytochrome c whose immune recognition requires two complementing major histocompatibility complex-linked immune response genes.
  The Journal of Experimental Medicine, 1979